Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEUROCRINE BIOSCIENCES INC | Chief Scientific Officer | Common Stock | 13.1K | $1.75M | $132.94 | Feb 13, 2024 | Direct |
NEUROCRINE BIOSCIENCES INC | Chief Scientific Officer | Restricted Stock Unit | 10.8K | $1.43M | $132.99 | Feb 13, 2024 | Direct |
NEUROCRINE BIOSCIENCES INC | Chief Scientific Officer | Stock Option | 54.1K | Feb 13, 2024 | Direct | ||
Voyager Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VYGR | Voyager Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
NBIX | NEUROCRINE BIOSCIENCES INC | Feb 13, 2024 | 3 | -$190K | 4 | Feb 15, 2024 | Chief Scientific Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | Jan 31, 2024 | 1 | -$17.9K | 4 | Feb 2, 2024 | Chief Scientific Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | Nov 29, 2023 | 1 | -$265K | 4 | Dec 1, 2023 | Chief Scientific Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | Aug 21, 2023 | 1 | -$343K | 4 | Aug 23, 2023 | Chief Scientific Officer |
VYGR | Voyager Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
VYGR | Voyager Therapeutics, Inc. | Feb 23, 2023 | 1 | $0 | 4 | Feb 27, 2023 | Director |
VYGR | Voyager Therapeutics, Inc. | Feb 23, 2023 | 0 | $0 | 3 | Feb 27, 2023 | Director |
NBIX | NEUROCRINE BIOSCIENCES INC | Feb 13, 2023 | 2 | $0 | 4 | Feb 15, 2023 | Chief Scientific Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | Feb 7, 2023 | 1 | -$461K | 4 | Feb 8, 2023 | Chief Scientific Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | Jan 31, 2023 | 1 | -$13.7K | 4 | Feb 2, 2023 | Chief Scientific Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | Nov 29, 2022 | 1 | -$284K | 4 | Dec 1, 2022 | Chief Scientific Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | Jan 31, 2022 | 2 | $0 | 4 | Feb 2, 2022 | Chief Scientific Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | Nov 29, 2021 | 2 | $0 | 4 | Dec 1, 2021 | Chief Scientific Officer |
NBIX | NEUROCRINE BIOSCIENCES INC | Nov 29, 2021 | 0 | $0 | 3 | Dec 1, 2021 | Chief Scientific Officer |